You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 6, December 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intra-aortic Balloon Pumping

Hemodynamic and Metabolic Effects During Cardiogenic Shock in Patients With Triple Coronary Artery Obstructive Disease

Donald N. Summers, MD; Martin Kaplitt, MD; Jay Norris, MD; Robert Rubin, MD; Robert Nacht, MD; Allan Arieff, MD; Myles Lee, MD; Bernard Wechsler, MD; Phillip N. Sawyer, MD

AMA Arch Surg. 1969;99(6):733-738.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Mechanical devices which maintain viability during periods of reduced or absent mechanical cardiac function have permitted the utilization of a variety of surgical techniques for the treatment of acquired and congenital cardiac disease. In addition, many advances in cardiac pharmacology have improved the treatment of abnormal mechanical and electrical cardiac function.

Despite a variety of therapeutic approaches, survival rate of hospital patients in cardiogenic shock remains between 10% to 20%.1 Malach and Rosenberg2 reviewed 264 consecutive cases of acute myocardial infarction at this institution and found the frequency of cardiogenic shock to be 9.4%. Those patients in shock were treated with several pharmacologic and volume replacement regimens with no survivors. More recently, Eichna3 reported on the treatment of 26 cardiogenic shock cases at this institution using intravenously administered isoproterenol hydrochloride as the major pharmacologic agent. The death rate was 72%. Drugs remain the most frequent means of . . . [Full Text PDF of this Article]


Author Affiliations

Brooklyn, NY

From the departments of medicine (Drs. Summers, Norris, Nacht, Arieff, and Wechsler) and surgery (Drs. Kaplitt, Rubin, Lee, and Sawyer), Downstate Medical Center, State University of New York, and Kings County Hospital Center, Brooklyn, NY.


Footnotes

Submitted for publication Aug 5, 1969.

Read before the 17th scientific meeting of the North American Chapter of the International Cardiovascular Society, New York, July 11, 1969.

Reprint requests to 450 Clark Ave, Brooklyn, NY 11203 (Dr. Summers).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.